These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 34171154)

  • 1. Variation in therapeutic strategies for the management of severe COVID-19 in India: A nationwide cross-sectional survey.
    Jagiasi B; Nasa P; Chanchalani G; Ahmed A; Ak AK; Sodhi K; Mangal K; Singh MK; Gupta N; Bidkar PU; Tyagi RS; Khanikar RG; Tripathy S; Khanzode S; Subba Reddy K; Saigal S; Sivakumar VA; Javeri Y; Tekwani SS
    Int J Clin Pract; 2021 Oct; 75(10):e14574. PubMed ID: 34171154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In search for a panacea for coronavirus disease-19: Analysis of ongoing clinical trials for the management of coronavirus disease-19 pandemic in India.
    Maheshwari N; Roy V
    Indian J Pharmacol; 2022; 54(4):258-269. PubMed ID: 36204809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of current clinical management guidelines for COVID-19 with special reference to India.
    Kumar R; Vinod KS; Mittal A; Adhikari SD; Gupta N
    Drug Discov Ther; 2020; 14(4):171-176. PubMed ID: 32908072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice Pattern of Critical Care Physicians in India for Use of Corticosteroids in COVID-19.
    Juneja D; Jain R; Singh O
    J Assoc Physicians India; 2021 May; 69(5):50-55. PubMed ID: 34189887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESCMID COVID-19 living guidelines: drug treatment and clinical management.
    Bartoletti M; Azap O; Barac A; Bussini L; Ergonul O; Krause R; Paño-Pardo JR; Power NR; Sibani M; Szabo BG; Tsiodras S; Verweij PE; Zollner-Schwetz I; Rodríguez-Baño J
    Clin Microbiol Infect; 2022 Feb; 28(2):222-238. PubMed ID: 34823008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021).
    Panovska-Stavridis I; Ridova N; Stojanoska T; Demiri I; Stevanovic M; Stojanovska S; Ristevska T; Dimkovski A; Filipce V; Dimovski A; Grozdanova A
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Apr; 42(1):5-18. PubMed ID: 33894123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical update on COVID-19 for the emergency and critical care clinician: Medical management.
    Long B; Chavez S; Carius BM; Brady WJ; Liang SY; Koyfman A; Gottlieb M
    Am J Emerg Med; 2022 Jun; 56():158-170. PubMed ID: 35397357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacology of COVID-19.
    Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
    Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19.
    Daou F; Abou-Sleymane G; Badro DA; Khanafer N; Tobaiqy M; Al Faraj A
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33499310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of coronavirus disease 2019.
    Hung IFN
    Curr Opin HIV AIDS; 2020 Nov; 15(6):336-340. PubMed ID: 33002954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic role of immunomodulators during the COVID-19 pandemic- a narrative review.
    Al-Hajeri H; Baroun F; Abutiban F; Al-Mutairi M; Ali Y; Alawadhi A; Albasri A; Aldei A; AlEnizi A; Alhadhood N; Al-Herz A; Alkadi A; Alkanderi W; Almathkoori A; Almutairi N; Alsayegh S; Alturki A; Bahbahani H; Dehrab A; Ghanem A; Haji Hasan E; Hayat S; Saleh K; Tarakmeh H;
    Postgrad Med; 2022 Mar; 134(2):160-179. PubMed ID: 35086413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive immunization and its rebirth in the era of the COVID-19 pandemic.
    Pavia CS; Wormser GP
    Int J Antimicrob Agents; 2021 Mar; 57(3):106275. PubMed ID: 33400975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19: Antiviral Agents, Antibody Development and Traditional Chinese Medicine.
    Guan W; Lan W; Zhang J; Zhao S; Ou J; Wu X; Yan Y; Wu J; Zhang Q
    Virol Sin; 2020 Dec; 35(6):685-698. PubMed ID: 32997322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging treatment strategies for COVID-19 infection.
    Gavriatopoulou M; Ntanasis-Stathopoulos I; Korompoki E; Fotiou D; Migkou M; Tzanninis IG; Psaltopoulou T; Kastritis E; Terpos E; Dimopoulos MA
    Clin Exp Med; 2021 May; 21(2):167-179. PubMed ID: 33128197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).
    Agarwal A; Mukherjee A; Kumar G; Chatterjee P; Bhatnagar T; Malhotra P;
    BMJ; 2020 Oct; 371():m3939. PubMed ID: 33093056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Scenario and Future Prospect in the Management of COVID-19.
    Borah P; Deb PK; Deka S; Venugopala KN; Singh V; Mailavaram RP; Kalia K; Tekade RK
    Curr Med Chem; 2021; 28(2):284-307. PubMed ID: 32900341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics-a review.
    Raj CTD; Kandaswamy DK; Danduga RCSR; Rajasabapathy R; James RA
    Arch Microbiol; 2021 Jul; 203(5):2043-2057. PubMed ID: 33555378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 management.
    Wilson KC
    Curr Opin Pulm Med; 2021 May; 27(3):169-175. PubMed ID: 33606409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent Plasma for Preventing Critical Illness in COVID-19: a Phase 2 Trial and Immune Profile.
    Sturek JM; Thomas TA; Gorham JD; Sheppard CA; Raymond AH; Petros De Guex K; Harrington WB; Barros AJ; Madden GR; Alkabab YM; Lu DY; Liu Q; Poulter MD; Mathers AJ; Thakur A; Schalk DL; Kubicka EM; Lum LG; Heysell SK
    Microbiol Spectr; 2022 Feb; 10(1):e0256021. PubMed ID: 35196802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
    Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
    JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.